Anebulo Pharmaceuticals Inc ANEB:NASDAQ

RT Quote | NASDAQ | USD
Last | 4:00 PM EDT
5.29quote price arrow down-0.20 (-3.64%)
Volume
279,610
52 week range
2.67 - 7.88
Loading...
  • Open6.48
  • Day High7.00
  • Day Low4.22
  • Prev Close5.49
  • 52 Week High7.88
  • 52 Week High Date02/01/22
  • 52 Week Low2.67
  • 52 Week Low Date06/17/22

Key Stats

  • Market Cap123.47M
  • Shares Out23.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.86

KEY STATS

  • Open6.48
  • Day High7.00
  • Day Low4.22
  • Prev Close5.49
  • 52 Week High7.88
  • 52 Week High Date02/01/22
  • 52 Week Low2.67
  • 52 Week Low Date06/17/22
  • Market Cap123.47M
  • Shares Out23.34M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-18.86

RATIOS/PROFITABILITY

  • EPS (TTM)-1.43
  • P/E (TTM)-3.71
  • Fwd P/E (NTM)-15.56
  • EBITDA (TTM)-6.99M
  • ROE (TTM)-870.07%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Anebulo Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Anebulo Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is engaged in developing solutions for people suffering from cannabinoid overdose and substance addiction. The Company's lead product candidate, ANEB-001, is a potent, small molecule cannabinoid receptor antagonist, designed to address the unmet medical need for a specific antidote for cannabinoid overdose. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety...
Address
1415 Ranch Road 629 South, Suite 201
Lakeway, TX
78734
United States

Top Peers

SYMBOLLASTCHG%CHG
ATOS
Atossa Therapeutics Inc
1.09+0.08+7.92%
PASG
Passage Bio Inc
2.48+0.10+4.20%
CTXR
Citius Pharmaceuticals Inc
0.8936-0.0005-0.0559%
NXTC
NextCure Inc
4.62+0.12+2.67%
TSHA
Taysha Gene Therapies Inc
3.52+0.07+2.03%